tiprankstipranks
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
US Market

Kezar Life Sciences (KZR) Financial Statements

Compare
466 Followers

Kezar Life Sciences Financial Overview

Kezar Life Sciences's market cap is currently $32.88M. The company's EPS TTM is $-11.486; its P/E ratio is ―; Kezar Life Sciences is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-2.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 7.00M$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 5.93M$ -1.02M$ -1.51M$ -1.54M
Operating Income$ -90.61M$ -105.24M$ -71.16M$ -54.66M$ -42.95M
EBITDA$ -90.61M$ -99.25M$ -66.11M$ -52.96M$ -40.26M
Net Income$ -83.74M$ -101.87M$ -65.32M$ -53.28M$ -38.99M
Balance Sheet
Cash & Short-Term Investments$ 132.25M$ 201.37M$ 276.56M$ 208.35M$ 140.45M
Total Assets$ 144.68M$ 221.24M$ 299.57M$ 217.93M$ 151.84M
Total Debt$ 11.07M$ 18.93M$ 21.26M$ 14.04M$ 5.46M
Net Debt$ -30.68M$ -16.56M$ -19.19M$ -48.84M$ -15.76M
Total Liabilities$ 27.77M$ 33.66M$ 29.70M$ 21.06M$ 10.86M
Stockholders' Equity$ 116.92M$ 187.57M$ 269.87M$ 196.88M$ 140.98M
Cash Flow
Free Cash Flow$ -74.24M$ -83.45M$ -60.42M$ -42.75M$ -37.14M
Operating Cash Flow$ -74.21M$ -81.64M$ -58.85M$ -42.44M$ -36.95M
Investing Cash Flow$ 80.43M$ 76.05M$ -91.39M$ -28.44M$ -56.50M
Financing Cash Flow$ 103.00K$ 638.00K$ 127.86M$ 112.58M$ 99.64M
Currency in USD

Kezar Life Sciences Earnings and Revenue History

Kezar Life Sciences Debt to Assets

Kezar Life Sciences Cash Flow

Kezar Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis